FDA accepts Viatris drug application for fast-acting meloxicam pain treatment
Go back to FDA accepts Viatris drug application for fast-acting meloxicam pain treatment| (NASDAQ: VTRS) | Delayed: 16.48 +0.17 (1.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.31 | 52 Week High | $ | |||
| Open | $16.47 | 52 Week Low | $ | |||
| Day High | $16.63 | P/E | N/A | |||
| Day Low | $16.33 | EPS | $ | |||
| Volume | 6,231,327 | |||||

